# Paulo Hoff

Source: https://onco.cc/people/hoff-paulo/  
OnCo record `hoff-paulo` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Brazil's most prominent GI oncologist, a former MD Anderson faculty member who built oncology programmes at Sírio-Libanês and ICESP.

## Summary

Paulo Hoff is a medical oncologist specialising in gastrointestinal cancer and a leader of Brazilian oncology through Hospital Sírio-Libanês, the University of São Paulo and Oncologia D'Or. A former MD Anderson faculty member, he led research on capecitabine and colorectal cancer there before returning to Brazil, where he directed the oncology centre at Sírio-Libanês and the São Paulo State Cancer Institute and later led Oncologia D'Or. His publications include the trial comparing oral capecitabine with intravenous fluorouracil plus leucovorin as first-line treatment for metastatic colorectal cancer. He is Brazil's most prominent gastrointestinal oncologist, with interests in colorectal cancer, clinical trials and oncology leadership.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Medical oncologist; gastrointestinal oncology; Brazilian oncology leadership (Sírio-Libanês, USP, Oncologia D'Or)
- Specialisms: Colorectal cancer; Gastrointestinal oncology; Clinical trials; Oncology leadership

## Sources

- Hospital Sírio-Libanês: https://www.hospitalsiriolibanes.org.br
- PubMed author search: https://pubmed.ncbi.nlm.nih.gov/?term=Hoff%20PM%5BAuthor%5D%20colorectal%20capecitabine

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/)
- drugs: [FOLFOX (5-FU, leucovorin, oxaliplatin)](https://onco.cc/drugs/folfox/)
- institutions: [Agência Nacional de Vigilância Sanitária](https://onco.cc/institutions/anvisa/), [Hospital Sírio-Libanês](https://onco.cc/institutions/sirio-libanes/)

---
JSON: https://onco.cc/api/v1/entities/hoff-paulo.json